Enzolytics Inc (ENZC)

[OTCShotCaller]

Re: My Post #44758 from today.

Now that Protheragen has been identified as the CRO that's been engaged in moving BioClonetics thru the various phases of candidate drug validation of their Clone-3 Ab (aka: Cl3hmAb seen 5th from the top of Protheragen's Program Pipline Chart on the link below),it's VERY CLEAR that Clone-3 has already passed through the "Discovery" Phase and is presently in the middle of the "Pre-Clinical" Phase that might include the planned Primate Studies at U.C. Davis.

https://www.protheragen.com/

This is extremely good news but for some reason it hasn't made it to public News channels.

When the Pre-Clinical Phase is complete, Clone-3 will then pass through all four industry standard Clinical Trials Phases, i.e. Phase I, II, III, and IV that's required for FDA certification, licensing, and commercialization. Early in this final process the PPS will definitely SOAR well into the Dollar range!!

It's anyone's guess if the chart on the above link is current and up to date, but my hunch is that it won't be long before Clone-3 enters Phase I of Patient Clinical Trials based on what see see on Protheragen's candidate drug development chart.

This paints an enhanced picture of just how far alone BioClonetics has come to bring Clone-3 to market.

I can say it's definitely reassuring to see this.

It may be a good idea to send Protheragen an email and ask them how long ago did BioClonetic's Clone-3 enter their drug development program and what Phase it's presently in.

Be well and prosper...